{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:34:16Z","timestamp":1707525256345},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,15]]},"DOI":"10.7759\/cureus.43539","type":"journal-article","created":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T22:25:16Z","timestamp":1692138316000},"source":"Crossref","is-referenced-by-count":0,"title":["SARS-CoV-2: Current Tools to Fight COVID-19 ST-Elevation Myocardial Infarction"],"prefix":"10.7759","author":[{"given":"Syed","family":"Ifthikar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Savoj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2020.04.014","article-title":"Severe COVID-19 infection associated with endothelial activation","volume":"190","author":"Escher R","year":"2020","unstructured":"Escher R, Breakey N, L\u00e4mmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020, 190:62. 10.1016\/j.thromres.2020.04.014","journal-title":"Thromb Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","volume":"8","author":"Fox SE","year":"2020","unstructured":"Fox SE, Akmatbekov A, Harbert JL, Li G, Quincy Brown J, Vander Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med. 2020, 8:681-6. 10.1016\/S2213-2600(20)30243-5","journal-title":"Lancet Respir Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016%2Fj.jaccas.2020.06.017","article-title":"The COVID-19 pandemic and cardiovascular complications: what have we learned so far?","volume":"2","author":"Walsh MN","year":"2020","unstructured":"Walsh MN, Sorgente A, Fischman DL, Bates ER, Grapsa J. The COVID-19 pandemic and cardiovascular complications: what have we learned so far?. JACC Case Rep. 2020, 2:1235-1239. 10.1016%2Fj.jaccas.2020.06.017","journal-title":"JACC Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.28946","article-title":"Management of acute myocardial infarction during the COVID-19 pandemic: a consensus statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP)","volume":"96","author":"Mahmud E","year":"2020","unstructured":"Mahmud E, Dauerman HL, Welt FG, et al.. Management of acute myocardial infarction during the COVID-19 pandemic: a consensus statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). Catheter Cardiovasc Interv. 2020, 96:336-45. 10.1002\/ccd.28946","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.07.004","article-title":"Trends and outcomes of fibrinolytic therapy for STEMI: insights and reflections in the COVID-19 era","volume":"13","author":"Elbadawi A","year":"2020","unstructured":"Elbadawi A, Mahtta D, Elgendy IY, et al.. Trends and outcomes of fibrinolytic therapy for STEMI: insights and reflections in the COVID-19 era. JACC Cardiovasc Interv. 2020, 13:2312-4. 10.1016\/j.jcin.2020.07.004","journal-title":"JACC Cardiovasc Interv"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016%2Fj.jaccas.2020.04.016","article-title":"COVID-19 STEMI 2020: it\u2019s not what you know, it\u2019s how you think","volume":"2","author":"Vidovich MI","year":"2020","unstructured":"Vidovich MI, Fischman DL, Bates ER . COVID-19 STEMI 2020: it\u2019s not what you know, it\u2019s how you think. JACC Case Rep. 2020, 2:1289-1290. 10.1016%2Fj.jaccas.2020.04.016","journal-title":"JACC Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177%2F0300060520966151","article-title":"Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic","volume":"48","author":"Wang N","year":"2020","unstructured":"Wang N, Zhang M, Su H, Huang Z, Lin Y, Zhang M. Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic. J Int Med Res. 2020, 48:2312-2314. 10.1177%2F0300060520966151","journal-title":"J Int Med Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.09.045","article-title":"The STRIATE-G technique for COVID-19 ST-segment elevation myocardial infarction","volume":"14","author":"Yerasi C","year":"2021","unstructured":"Yerasi C, Khalid N, Khan JM, Hashim H, Waksman R, Bernardo N. The STRIATE-G technique for COVID-19 ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2021, 14:345-6. 10.1016\/j.jcin.2020.09.045","journal-title":"JACC Cardiovasc Interv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.28167","article-title":"The combined use of stent retriever and neuro-aspiration as successful bail-out reperfusion strategy in a patient with embolic myocardial infarction","volume":"94","author":"Crimi G","year":"2019","unstructured":"Crimi G, Moramarco L, Mandurino-Mirizzi A, Quaretti P, Ferrario M. The combined use of stent retriever and neuro-aspiration as successful bail-out reperfusion strategy in a patient with embolic myocardial infarction. Catheter Cardiovasc Interv. 2019, 94:E78-81. 10.1002\/ccd.28167","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093%2Feurheartj%2Fehaa399","article-title":"ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome","volume":"22","author":"Ueki Y","year":"2020","unstructured":"Ueki Y, Otsuka T, Windecker S, R\u00e4ber L. ST-elevation myocardial infarction and pulmonary embolism in a patient with COVID-19 acute respiratory distress syndrome. Our Heart J. 2020, 22:2134-2134. 10.1093%2Feurheartj%2Fehaa399","journal-title":"Our Heart J"},{"key":"ref11","article-title":"Excimer laser revascularization of saphenous vein grafts in acute myocardial infarction","volume":"16","author":"Ebersole D","year":"2004","unstructured":"Ebersole D, Dahm JB, Das T, et al.. Excimer laser revascularization of saphenous vein grafts in acute myocardial infarction. J Invasive Cardiol. 2004, 16:177-80.","journal-title":"J Invasive Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2017.01.011","article-title":"Orbital atherectomy for treating de novo, severely calcified coronary lesions: 3-year results of the pivotal ORBIT II trial","volume":"18","author":"Lee M","year":"2017","unstructured":"Lee M, G\u00e9n\u00e9reux P, Shlofmitz R, et al.. Orbital atherectomy for treating de novo, severely calcified coronary lesions: 3-year results of the pivotal ORBIT II trial. Cardiovasc Revasc Med. 2017, 18:261-4. 10.1016\/j.carrev.2017.01.011","journal-title":"Cardiovasc Revasc Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2017.01.025","article-title":"Comparison of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary plaques","volume":"119","author":"Lee MS","year":"2017","unstructured":"Lee MS, Park KW, Shlofmitz E, Shlofmitz RA. Comparison of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary plaques. Am J Cardiol. 2017, 119:1320-3. 10.1016\/j.amjcard.2017.01.025","journal-title":"Am J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.119.008434","article-title":"Safety and effectiveness of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: the Disrupt CAD II study","volume":"12","author":"Ali ZA","year":"2019","unstructured":"Ali ZA, Nef H, Escaned J, et al.. Safety and effectiveness of coronary intravascular lithotripsy for treatment of severely calcified coronary stenoses: the Disrupt CAD II study. Circ Cardiovasc Interv. 2019, 12:e008434. 10.1161\/CIRCINTERVENTIONS.119.008434","journal-title":"Circ Cardiovasc Interv"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60924-7","article-title":"Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial","volume":"384","author":"Shahzad A","year":"2014","unstructured":"Shahzad A, Kemp I, Mars C, et al.. Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial. Lancet. 2014, 384:1849-1858. 10.1016\/S0140-6736(14)60924-7","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin L","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, et al.. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009, 361:1045-57. 10.1056\/NEJMoa0904327","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908973","article-title":"Ticagrelor or prasugrel in patients with acute coronary syndromes","volume":"381","author":"Sch\u00fcpke S","year":"2019","unstructured":"Sch\u00fcpke S, Neumann FJ, Menichelli M, et al.. Ticagrelor or prasugrel in patients with acute coronary syndromes. N Engl J Med. 2019, 381:1524-34. 10.1056\/NEJMoa1908973","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.09.586","article-title":"Ticagrelor or prasugrel for platelet inhibition in acute coronary syndrome patients: the ISAR-REACT 5 trial","volume":"76","author":"Mayer K","year":"2020","unstructured":"Mayer K, Bongiovanni D, Karschin V, et al.. Ticagrelor or prasugrel for platelet inhibition in acute coronary syndrome patients: the ISAR-REACT 5 trial. J Am Coll Cardiol. 2020, 76:2569-71. 10.1016\/j.jacc.2020.09.586","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-08-0560","article-title":"Efficacy of abciximab for patients undergoing balloon angioplasty: data from Japanese evaluation of c7E3 Fab for elective and primary PCI organization in randomized trial (JEPPORT)","volume":"73","author":"Nakagawa Y","year":"2009","unstructured":"Nakagawa Y, Nobuyoshi M, Yamaguchi T, et al.. Efficacy of abciximab for patients undergoing balloon angioplasty: data from Japanese evaluation of c7E3 Fab for elective and primary PCI organization in randomized trial (JEPPORT). Circ J. 2009, 73:145-51. 10.1253\/circj.cj-08-0560","journal-title":"Circ J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009337942","article-title":"Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38","volume":"49","author":"Wrishko RE","year":"2009","unstructured":"Wrishko RE, Ernest CS 2nd, Small DS, et al.. Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38. J Clin Pharmacol. 2009, 49:984-98. 10.1177\/0091270009337942","journal-title":"J Clin Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/105925-sars-cov-2-current-tools-to-fight-covid-19-st-elevation-myocardial-infarction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:02Z","timestamp":1707508982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/105925-sars-cov-2-current-tools-to-fight-covid-19-st-elevation-myocardial-infarction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.43539","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,15]]}}}